These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of umbilical cord tissue and meconium for the confirmation of in utero drug exposure. Colby JM Clin Biochem; 2017 Sep; 50(13-14):784-790. PubMed ID: 28288850 [TBL] [Abstract][Full Text] [Related]
3. Umbilical Cord Tissue and Meconium May Not Be Equivalent for Confirming in Utero Substance Exposure. Colby JM; Adams BC; Morad A; Presley LD; Patrick SW J Pediatr; 2019 Feb; 205():277-280. PubMed ID: 30342870 [TBL] [Abstract][Full Text] [Related]
4. Alternative matrices for cocaine, heroin, and methadone in utero drug exposure detection. Concheiro M; González-Colmenero E; Lendoiro E; Concheiro-Guisán A; de Castro A; Cruz-Landeira A; López-Rivadulla M Ther Drug Monit; 2013 Aug; 35(4):502-9. PubMed ID: 23851907 [TBL] [Abstract][Full Text] [Related]
5. Testing for fetal exposure to illicit drugs using umbilical cord tissue vs meconium. Montgomery D; Plate C; Alder SC; Jones M; Jones J; Christensen RD J Perinatol; 2006 Jan; 26(1):11-4. PubMed ID: 16281047 [TBL] [Abstract][Full Text] [Related]
6. Evaluating a switch from meconium to umbilical cord tissue for newborn drug testing: A retrospective study at an academic medical center. Palmer KL; Wood KE; Krasowski MD Clin Biochem; 2017 Apr; 50(6):255-261. PubMed ID: 27890824 [TBL] [Abstract][Full Text] [Related]
7. Bioanalysis for cocaine, opiates, methadone, and amphetamines exposure detection during pregnancy. Concheiro M; Lendoiro E; de Castro A; Gónzalez-Colmenero E; Concheiro-Guisan A; Peñas-Silva P; Macias-Cortiña M; Cruz-Landeira A; López-Rivadulla M Drug Test Anal; 2017 Jun; 9(6):898-904. PubMed ID: 27595432 [TBL] [Abstract][Full Text] [Related]
8. Methadone, cocaine, opiates, and metabolite disposition in umbilical cord and correlations to maternal methadone dose and neonatal outcomes. de Castro A; Jones HE; Johnson RE; Gray TR; Shakleya DM; Huestis MA Ther Drug Monit; 2011 Aug; 33(4):443-52. PubMed ID: 21743375 [TBL] [Abstract][Full Text] [Related]
9. Assessment of biological matrices for the detection of in utero cannabis exposure. Concheiro M; Gutierrez FM; Ocampo A; Lendoiro E; González-Colmenero E; Concheiro-Guisán A; Peñas-Silva P; Macías-Cortiña M; Cruz-Landeira A; López-Rivadulla M; de-Castro-Ríos A Drug Test Anal; 2021 Jul; 13(7):1371-1382. PubMed ID: 33750017 [TBL] [Abstract][Full Text] [Related]
10. Using umbilical cord tissue to detect fetal exposure to illicit drugs: a multicentered study in Utah and New Jersey. Montgomery DP; Plate CA; Jones M; Jones J; Rios R; Lambert DK; Schumtz N; Wiedmeier SE; Burnett J; Ail S; Brandel D; Maichuck G; Durham CA; Henry E; Christensen RD J Perinatol; 2008 Nov; 28(11):750-3. PubMed ID: 18596707 [TBL] [Abstract][Full Text] [Related]
11. Nicotine and metabolites in paired umbilical cord tissue and meconium specimens. Marin SJ; Christensen RD; Baer VL; Clark CJ; McMillin GA Ther Drug Monit; 2011 Feb; 33(1):80-5. PubMed ID: 21192312 [TBL] [Abstract][Full Text] [Related]
12. Detection of neonatal drug exposure using umbilical cord tissue and liquid chromatography time-of-flight mass spectrometry. Marin SJ; Metcalf A; Krasowski MD; Linert BS; Clark CJ; Strathmann FG; McMillin GA Ther Drug Monit; 2014 Feb; 36(1):119-24. PubMed ID: 24061447 [TBL] [Abstract][Full Text] [Related]
13. Drugs of abuse testing in meconium. Gareri J; Klein J; Koren G Clin Chim Acta; 2006 Apr; 366(1-2):101-11. PubMed ID: 16413011 [TBL] [Abstract][Full Text] [Related]
15. Can Umbilical Cord and Meconium Results Be Directly Compared? Analytical Approach Matters. Pandya V; Wilker C; McMillin GA J Anal Toxicol; 2023 Feb; 47(1):96-105. PubMed ID: 35707888 [TBL] [Abstract][Full Text] [Related]
16. Umbilical cord monitoring of in utero drug exposure to buprenorphine and correlation with maternal dose and neonatal outcomes. Concheiro M; Jones HE; Johnson RE; Choo R; Shakleya DM; Huestis MA J Anal Toxicol; 2010 Oct; 34(8):498-505. PubMed ID: 21819795 [TBL] [Abstract][Full Text] [Related]
17. Screening for Opioid and Stimulant Exposure In Utero Through Targeted and Untargeted Metabolomics Analysis of Umbilical Cords. Mamillapalli SS; Smith-Joyner A; Forbes L; McIntyre K; Poppenfuse S; Rushing B; Strom C; Danell AS; May L; Kuehn D; Kew K; Ravisankar S Ther Drug Monit; 2020 Oct; 42(5):787-794. PubMed ID: 32142018 [TBL] [Abstract][Full Text] [Related]
18. Alarming prevalence of fetal alcohol exposure in a Mediterranean city. Garcia-Algar O; Kulaga V; Gareri J; Koren G; Vall O; Zuccaro P; Pacifici R; Pichini S Ther Drug Monit; 2008 Apr; 30(2):249-54. PubMed ID: 18367990 [TBL] [Abstract][Full Text] [Related]
19. Drug testing in biological samples vs. maternal surveys for the detection of substance use during whole pregnancy. González-Colmenero E; Concheiro-Guisán A; Lorenzo-Martínez M; Concheiro M; Lendoiro E; de-Castro-Ríos A; Cañizo-Vázquez D; Martínez-Reglero C; Fernández-Lorenzo JR J Addict Dis; 2021; 39(2):175-182. PubMed ID: 33043834 [TBL] [Abstract][Full Text] [Related]
20. Comparison of Biological Screening and Diagnostic Indicators to Detect In Utero Opiate and Cocaine Exposure Among Mother-Infant Dyads. Stabler M; Giacobbi P; Chertok I; Long L; Cottrell L; Yossuck P Ther Drug Monit; 2017 Dec; 39(6):640-647. PubMed ID: 28937537 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]